Among men who have sex with men, ‘pre-exposure prophylaxis’, or PrEP, has apparently led to a fall in condom use. Condoms, 100% of the time: that was the HIV-prevention policy Adam MacLean, 36, observed with casual male partners ever since he came out in 1999.
All news from Venereology
Hispanic / Latino women with HIV infection face more socioeconomic and language challenges than men, but the clinical outcomes are similar, according to research published in the Oct. 12 issue of the US Centers for Disease Control and Prevention Morbidity and Mortality Weekly Report
A seven-day dose of metronidazole is associated with a reduced likelihood of being Trichomonas vaginalis-positive at test-of-cure compared with single-dose treatment, according to a study published online Oct. 5 in The Lancet Infectious Diseases.
Infants born to HIV-positive mothers had high rates of congenital cytomegalovirus or CMV. Infants who were also infected before birth by the virus that causes AIDS were especially prone to CMV infection.
According to an online survey, although healthcare providers (HCPs) report sharing crucial information on bacterial vaginosis (BV) with patients, the associated risks of the condition remain a mystery to many women, indicating a significant disconnect. With BV known to be the most prevalent gynecologic infection in the U.S., affecting 21 million women each year, it's clear that further education is needed to bridge this gap in communication and help women to obtain diagnosis and treatment initiation sooner.
A new study led by an infectious disease epidemiologist at Tulane University School of Public Health and Tropical Medicine could change the way doctors treat a common sexually transmitted disease.
It has been well established that HIV transmission can be efficiently halted by effective treatment of those infected or by pre-exposure prophylaxis of individuals at risk of exposure. However, the effectiveness of these approaches to prevent HIV transmission require strict adherence to dosing regimens.
An HIV outbreak among people who inject drugs in Indiana from 2011 to 2015 could have been avoided if the state's top health and elected officials had acted sooner on warnings, a new study by the Yale School of Public Health finds.
Researchers at the BC Centre for Excellence in HIV/AIDS (BC-CfE) and Simon Fraser University (SFU), in partnership with University of British Columbia (UBC) and Western University, have developed a novel way for dating "hibernating" HIV strains, in an advancement for HIV cure research in the province.
Published in Proceedings of the National Academy of Sciences (PNAS), the BC-CfE's first major scientific contribution to the area of HIV cure research confirms that dormant HIV strains can persist in the body for decades.
Immune activation and inflammation persist in the majority of treated HIV-infected individuals and is associated with excess risk of mortality and morbidity.
A new study suggests that use of HIV RNA expression inhibitors as adjunct therapy might diminish atypical inflammation and restore immune function in HIV-infected individuals on combination antiretroviral therapy (cART). These findings appear online in the journal Nature Communications.
People who use HIV pre-exposure prophylaxis (PrEP) are also more likely to get routine care like flu shots and recommended screenings for common health problems, a U.S. study suggests.
Neisseria gonorrhoea continues to show high levels of resistance to azithromycin across the European Union and European Economic Area, according to the 2016 results of the European Gonococcal Antimicrobial Surveillance Programme (Euro-GASP).
This threatens the effectiveness of the currently recommended dual therapy regimen for gonorrhoea. Overall, the rates of resistance to cefixime, ceftriaxone and azithromycin have remained stable when compared to recent years.